Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Week Ahead: Stocks, Oil To Keep Wavering On Lockdown Woe Vs. Vaccine Optimism

By Investing.com (Pinchas Cohen/Investing.com)Market OverviewNov 22, 2020 08:30AM ET
www.investing.com/analysis/week-ahead-lockdown-volatility-200545417
Week Ahead: Stocks, Oil To Keep Wavering On Lockdown Woe Vs. Vaccine Optimism
By Investing.com (Pinchas Cohen/Investing.com)   |  Nov 22, 2020 08:30AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
  • Despite haven status and dollar weakness, gold slump continues
  • On Friday, oil climbed on vaccine progress even as stocks fell on lockdown distress

COVID-19 is likely to remain the dominant market theme in the coming, holiday-shortened week. The rising trajectory of the pandemic versus ongoing progress toward a vaccine will cause investors to whipsaw wildly between pessimism and optimism, driving markets lower or higher depending on prevailing sentiment.

Last week played out much as we predicted, when positive vaccine news dominated headlines, stocks advanced. But when the focus shifted to the unbridled rate of global and domestic contagion and stricter lockdowns, stocks sold off. Proving the point yet again on Friday, US coronavirus infections were headed toward the 12 million mark, with nearly 200,000 new cases reported on Friday, and stocks were mostly sold-off to finish the trading week.

Sector Rotation Fluctuates But Biotechs Rise

Losses for some US indices deepened on Friday. The S&P 500 and Dow Jones Industrial Average both ended the week lower; the NASDAQ dipped on Friday but was still up 0.2% for the week. The small cap Russell 2000, however, remained in positive territory all week.

Adding to the already significant pressure on stocks, conflict over the use of Federal Reserve funds overshadowed any positive news from the pharmaceuticals sector. Thursday, Treasury Secretary Steven Mnuchin requested the Fed return funds set aside for emergency lending, setting up the expiration of several relief programs by Dec. 31.

The Fed argued for extending “the full suite of emergency facilities,” and has no legal obligation to refund the Treasury's investment. However, in a letter on Friday To Mnuchin, Fed Chairman Jerome Powell said the central bank will "work out arrangements with you for returning the unused portions of the funds."

The rotation out of big tech shares, into sectors sensitive to an expanding economic cycle fluctuated throughout the week. This shift—between growth and value stocks such as those in the energy and financials sectors—will continue. Another type of rotation has also been taking place, a move into small caps and international shares and away from US large and mega cap stocks. Finally, there's a third, less visible rotation also occurring, between different investment styles: a move into dividend income shares and away from capital appreciation stocks.

As well, biotech shares remained headline sensitive.

Pfizer (NYSE:PFE) and German vaccine-development partner BioNTech (NASDAQ:BNTX) both gained after they submitted an emergency authorization request on Friday with the US's Food and Drug Administration (FDA) for rapid approval for their coronavirus inoculation.

BNTX Daily
BNTX Daily

Technically, BioNtech soared +9.5%, completing a bullish Island Reversal. Pfizer, however, added only 1.4%, having given up a 3.1% advance.

Shares of Gilead Sciences (NASDAQ:GILD) dropped after the World Health Organization (WHO) advised doctors not to administer the Foster City, California-based biopharmaceutical company's remdesivir, even after the US FDA approved it for hospitalized patients. WHO said there was no evidence for improved patient survival.

GILD Daily
GILD Daily

GILD price pressed against the bottom of a bearish flag, confirming the previous broken support, in place since Dec. 20, 2018.

Of course, we’ve been warning for some time now that whatever apparent progress pharmaceutical companies make in the fight against coronovirus, it doesn’t mean the worst pandemic in a century will magically disappear. Experts are predicting it will take four to six months at the very least for life to return to some sort of pre-pandemic normal.

Last week's initial jobless claims data was worse than anticipated, suggesting a choppier recovery than had been hoped for.

For all the volatility last week, the VIX ended dropping for a second week.

Yields, including for the 10-year Treasury benchmark note, erased a weekly loss.

UST  10Y Daily
UST 10Y Daily

On Friday, rates formed an inverted hammer upon a return to the bottom of a rising channel, suggesting a continued rise.

The dollar fell throughout the week.

Dollar Daily
Dollar Daily

This strengthened the resistance of a H&S neckline but hammered out a support at the initial penetration’s low, which coincides with the lows before forming the neckline.

Gold was up Friday but down for the week, even though both the dollar and stocks were lower as well.

Gold Daily
Gold Daily

This is the second time we’ve noticed gold being sold off while it should have risen either on its safe haven status, when stocks were down, or on a falling dollar.

Also, technically, the precious metal continued to elude our calls; after shifting between different patterns we remain expectant of an upside breakout of a falling wedge.

Bitcoin extended an advance for a seventh consecutive week, its longest upside run since May. Last week, the digital currency gained 16.2%, its best week since June 2019. The cryptocurrency reached a three-year high, nearing its all-time record of close to $20,000, hit during December 2017. The upmove notwithstanding, we consider Bitcoin overbought.

The Energy Information Administration reported that commercial crude oil inventories rose by 4.3 million barrels to 4.887 barrels, while analysts had anticipated a drop of 913,000.

Cushing oil inventories jumped 61.6 million barrels, bringing crude stocks to 81% capacity, or 76 million barrels. This is nearing its highest levels since April when a lack of storage space amid evaporating demand sent the price of oil into subzero territory.

Nevertheless, the price of oil jumped on Friday, to lock in a third weekly advance on the hopes that the two recent vaccine developments will eventually help spur the global economy and thus demand.

Oil Daily
Oil Daily

Technically, the price is forcing against the range top since Sept. 18. It needs to rise above the Nov. 11 shooting star and the rising wedge top to clear out any lagging supply. Otherwise, we expect it to return to the range, with momentum potentially pushing oil back toward $36.

Week Ahead

All times listed are EST

Monday

Japan's markets closed for the Workers Day holiday

3:30: Germany – Manufacturing PMI: seen to decline to 56.5 from 58.2.

4:30: UK – Manufacturing PMI: anticipated to remain flat at 53.3.

4:30: UK – Services PMI: expected to stay at 52.3.

9:45: US – Manufacturing PMI: likely slipped to 53.0 from 53.4.

Tuesday

2:00: Germany – GDP: expected to have remained steady at 8.2% in Q3.

4:00: Germany – Ifo Business Climate Index: probably slipped to 90.7 from 92.7

9:00: Eurozone – ECB President Lagarde Speaks

10:00: US – CB Consumer Confidence: seen to decline to 98.0 from 100.9.

Wednesday

8:30: US – Core Durable Goods Orders: anticipated to drop to 0.4% from 0.8%.

8:30: US – GDP: likely to have remained flat at 33.1% in Q3.

8:30: US – Initial Jobless Claims: expected to slacken to 725K from 742K.

10:00: US – New Home Sales: forecast to increase to 975K from 959K.

14:00: US – FOMC Meeting Minutes

Thursday

US markets closed for the Thanksgiving Day holiday

6:30: Eurozone – ECB Publishes Account of Monetary Policy Meeting

7:30: Eurozone – ECB Monetary Policy Statement

20:00: Japan – Tokyo Core CPI: seen to have dropped to -0.7% from -0.5%.

Friday

2:00: UK – Nationwide HPI: anticipated to have contracted to 0.2% from 0.8%.

Week Ahead: Stocks, Oil To Keep Wavering On Lockdown Woe Vs. Vaccine Optimism
 

Related Articles

Week Ahead: Stocks, Oil To Keep Wavering On Lockdown Woe Vs. Vaccine Optimism

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (2)
Jacob Steinschlag
Jacob Steinschlag Nov 22, 2020 2:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I noticed you recently analyzed bitcoin a bit - please take into account that we are in a current halving run (exactly like 4 years ago). I expected it to hit the 19500-20000 resistance and then to sell off towards 13-15k, because even for a halving run it is going to fast. According to historical halving data with halving runs aths 10000% and 3400% of halving date we consider the pricr target of this halving run to be 1200% of halving value - which is roughly 100k. Cheers!
jonah gaff
jonah gaff Nov 22, 2020 1:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
rushing vaccines will not help. infact rushed vaccines tend to be more deadly then thw actual disease.
Pinchas Cohen
Pinchas Cohen Nov 22, 2020 1:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I don't disagree with you.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email